Abivax SA

Abivax SA(ABVX)价格预测

$114.035

+3.033 (+2.66%)收盘时

价格预测

1-Day Price Prediction
-0.40%
1-Week Prediction
-12.48%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中打开以解锁更长周期的预测。

Loading chart…

ABVX 相似图表分析预测

Alphio's ABVX stock price prediction model matches the current Abivax SA tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $113.58 (-0.40%). The 1-week path is $99.80 (-12.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Abivax SA 股票吗?

Abivax SA is a good buy right now due to its recent funding of $920 million, which supports the U.S. launch of its drug obefazimod, and the positive analyst ratings with targets up to $180. The current RSI of 27.033 indicates the stock is oversold, suggesting a potential rebound. However, the main risk is the negative forward P/E ratio of 0, indicating uncertainty in future earnings performance.

ABVX 股价于 Thursday 收于 $114.04,此前上涨 +2.66%

Abivax SA (ABVX) last closed at $114.035, gaining +2.66%. These facts feed the 1-day and 1-week ABVX price prediction above.

预测驱动因素

Abivax SA(ABVX)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 ABVX 最接近的股票,按相似度排序。

ABVX 季节性分析

Historically the probability of a positive September return for ABVX is 93.18%. September offers the highest probability of a positive month at 93.18%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始